Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling
- PMID: 12668877
- DOI: 10.1385/endo:20:1-2:123
Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling
Abstract
Previously we showed that the distal element (DE) (-427 to -336 bp) within the pim-1 promoter appeared to regulate its prolactin (PRL)-induced transcription. To determine which specific DE sequences conferred PRL responsiveness, seven 12-bp deletion mutants ligated upstream of the chloramphenicol acetyltransferase gene were transfected into FDC/Nb2 cells. Results from promoter/ reporter studies showed that sequential 12-bp deletions of the DE significantly (p < 0.001) reduced PRL responsiveness. An additional site, nuclear factor-1 (-224 to -217), was also mutated by deletion or point mutation; both abrogated promoter activation by PRL (p < 0.0001). In other experiments, PRL signaling to pim-1 expression was investigated in FDC/Nb2 cells stably expressing the wild-type (WT) Jak2 cDNA or a carboxy-terminal kinase-deficient Jak2 mutant and in cells infected with adenoviral constructs of WT-Akt or dominant negative Akt. Altered Jak2 did not affect PRL-stimulated pim-1 expression while inhibition of Akt attenuated its transcription. We conclude that the DE and NF-1 half-site mediate PRL responsiveness of the pim-1 promoter. Moreover, the accumulated evidence does not support a role for the Jak2/Stat signaling pathway but, instead, implicates that Akt activation was a component of PRL-induced pim-1 transcription.
Similar articles
-
Prolactin regulation of pim-1 expression: positive and negative promoter elements.Endocrinology. 1999 Dec;140(12):5659-68. doi: 10.1210/endo.140.12.7215. Endocrinology. 1999. PMID: 10579330
-
Transcriptional regulation of pim-1 by prolactin: independence of a requirement for Jak2/Stat signaling.J Neuroimmunol. 2000 Sep 1;109(1):40-6. doi: 10.1016/s0165-5728(00)00301-5. J Neuroimmunol. 2000. PMID: 10969180
-
Prolactin signaling to pim-1 expression: a role for phosphatidylinositol 3-kinase.J Neuroimmunol. 2001 Feb 15;113(2):249-59. doi: 10.1016/s0165-5728(00)00430-6. J Neuroimmunol. 2001. PMID: 11164909
-
Prolactin regulation of estrogen receptor expression.Trends Endocrinol Metab. 2003 Apr;14(3):118-23. doi: 10.1016/s1043-2760(03)00030-4. Trends Endocrinol Metab. 2003. PMID: 12670737 Review.
-
STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5.Cytokine Growth Factor Rev. 2004 Dec;15(6):435-55. doi: 10.1016/j.cytogfr.2004.09.001. Cytokine Growth Factor Rev. 2004. PMID: 15561601 Review.
Cited by
-
PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells.Int J Mol Sci. 2021 Oct 15;22(20):11126. doi: 10.3390/ijms222011126. Int J Mol Sci. 2021. PMID: 34681783 Free PMC article.
-
The Role of PIM Kinases in Pediatric Solid Tumors.Cancers (Basel). 2022 Jul 22;14(15):3565. doi: 10.3390/cancers14153565. Cancers (Basel). 2022. PMID: 35892829 Free PMC article. Review.
-
Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1.PLoS One. 2012;7(3):e33194. doi: 10.1371/journal.pone.0033194. Epub 2012 Mar 8. PLoS One. 2012. PMID: 22413002 Free PMC article.
-
Why target PIM1 for cancer diagnosis and treatment?Future Oncol. 2010 Sep;6(9):1461-78. doi: 10.2217/fon.10.106. Future Oncol. 2010. PMID: 20919829 Free PMC article. Review.
-
PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.J Clin Invest. 2009 Feb;119(2):362-75. doi: 10.1172/JCI33216. Epub 2009 Jan 19. J Clin Invest. 2009. PMID: 19147983 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous